| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A case of allogeneic hematopoietic stem cell transplantation for primary plasma cell leukemia after treatment with daratumumab
|
Horisawa, Yoshihito
|
|
|
99 |
11 |
p. 2699-2701
|
artikel
|
| 2 |
A case of “double hit” mantle cell lymphoma carrying CCND1 and MYC translocations relapsed/refractory to rituximab bendamustine cytarabine (R-BAC) and ibrutinib
|
Scapinello, Greta
|
|
|
99 |
11 |
p. 2715-2717
|
artikel
|
| 3 |
A retrospective analysis on anti-CD20 antibody–treated Epstein–Barr virus–related posttransplantation lymphoproliferative disorder following ATG-based haploidentical T-replete hematopoietic stem cell transplantation
|
Luo, Xue-Yi
|
|
|
99 |
11 |
p. 2649-2657
|
artikel
|
| 4 |
Association of three factors (ABCB1 gene expression, steroid response, early response at day + 8) on the response to induction in patients with acute lymphoblastic leukemia
|
Ramos-Peñafiel, Christian
|
|
|
99 |
11 |
p. 2629-2637
|
artikel
|
| 5 |
Atypical presentation of a central nervous system aspergillosis in a peripheral T cell lymphoma patient
|
Larroquette, Mathieu
|
|
|
99 |
11 |
p. 2711-2713
|
artikel
|
| 6 |
Biallelic rare 17 bp deletion mutation (HBB:c.380_396 del TGCAGGCTGCCTATCAG) in a transfusion depended form of thalassemia
|
Tripathi, Poonam
|
|
|
99 |
11 |
p. 2719-2722
|
artikel
|
| 7 |
Biological properties of bone marrow plasma cells influence their recovery in aspirate specimens: impact on classification of plasma cell disorders and potential bias to evaluation of treatment response
|
Demyanets, Svitlana
|
|
|
99 |
11 |
p. 2599-2609
|
artikel
|
| 8 |
Clinical outcomes and healthcare utilization in patients with sickle cell disease: a nationwide cohort study of Medicaid beneficiaries
|
Desai, Rishi J.
|
|
|
99 |
11 |
p. 2497-2505
|
artikel
|
| 9 |
Clozapine-induced agranulocytosis
|
Mijovic, Aleksandar
|
|
|
99 |
11 |
p. 2477-2482
|
artikel
|
| 10 |
Comparative study on allogeneic with autologous hematopoietic stem cell transplantation in adult patients with Philadelphia chromosome–positive acute lymphoblastic leukemia in the era of TKIs: a systematic review and meta-analysis
|
Wei, Haichen
|
|
|
99 |
11 |
p. 2619-2628
|
artikel
|
| 11 |
Comparison of different cytomegalovirus diseases following haploidentical hematopoietic stem cell transplantation
|
Meng, Xing-Ye
|
|
|
99 |
11 |
p. 2659-2670
|
artikel
|
| 12 |
Correction to: Fractionated ifosfamide, carboplatin, and etoposide with rituximab as a safe and effective treatment for relapsed/refractory diffuse large B cell lymphoma with severe comorbidities
|
Tanaka, Norina
|
|
|
99 |
11 |
p. 2587
|
artikel
|
| 13 |
Detection of EP300-ZNF384 fusion in patients with acute lymphoblastic leukemia using RNA fusion gene panel sequencing
|
Jing, Yu
|
|
|
99 |
11 |
p. 2611-2617
|
artikel
|
| 14 |
Direct comparison of two extended half-life PEGylated recombinant FVIII products: a randomized, crossover pharmacokinetic study in patients with severe hemophilia A
|
Solms, Alexander
|
|
|
99 |
11 |
p. 2689-2698
|
artikel
|
| 15 |
Eltrombopag treatment promotes platelet recovery and reduces platelet transfusion for patients with post-transplantation thrombocytopenia
|
Gao, Fei
|
|
|
99 |
11 |
p. 2679-2687
|
artikel
|
| 16 |
Expansion of paroxysmal nocturnal hemoglobinuria clones in MPLW515L mutation harboring primary myelofibrosis
|
Kirito, Keita
|
|
|
99 |
11 |
p. 2707-2709
|
artikel
|
| 17 |
Fractionated ifosfamide, carboplatin, and etoposide with rituximab as a safe and effective treatment for relapsed/refractory diffuse large B cell lymphoma with severe comorbidities
|
Tanaka, Norina
|
|
|
99 |
11 |
p. 2577-2586
|
artikel
|
| 18 |
Hepatic and cardiac iron load as determined by MRI T2* in patients with congenital dyserythropoietic anemia type I
|
Asleh, Mahdi
|
|
|
99 |
11 |
p. 2507-2512
|
artikel
|
| 19 |
Hepatitis B reactivation in hematopoietic stem cell transplanted patients: 20 years of experience of a single center from a middle endemic country
|
Murt, Ahmet
|
|
|
99 |
11 |
p. 2671-2677
|
artikel
|
| 20 |
Incidence, risk factors and outcome of extramedullary relapse after allogeneic hematopoietic stem cell transplantation in patients with adult acute lymphoblastic leukemia
|
Yu, Jian
|
|
|
99 |
11 |
p. 2639-2648
|
artikel
|
| 21 |
Ixazomib-based frontline therapy in patients with newly diagnosed multiple myeloma in real-life practice showed comparable efficacy and safety profile with those reported in clinical trial: a multi-center study
|
Li, Jing
|
|
|
99 |
11 |
p. 2589-2598
|
artikel
|
| 22 |
Myelomatous pleural effusion with plasmablastic morphology and high genetic complexity as isolated extramedullary relapse
|
Martín-Moro, Fernando
|
|
|
99 |
11 |
p. 2705-2706
|
artikel
|
| 23 |
Nivolumab for relapsed or refractory Hodgkin lymphoma: real-life experience
|
Bekoz, Huseyin
|
|
|
99 |
11 |
p. 2565-2576
|
artikel
|
| 24 |
Prevalence of anaemia and associated risk factors amongst The Malaysian Cohort participants
|
Abdullah, Noraidatulakma
|
|
|
99 |
11 |
p. 2521-2527
|
artikel
|
| 25 |
Real-world risk assessment and treatment initiation among patients with myelofibrosis at community oncology practices in the United States
|
Verstovsek, Srdan
|
|
|
99 |
11 |
p. 2555-2564
|
artikel
|
| 26 |
Residual disease by flow cytometry in patients with nucleophosmin-mutated acute myeloblastic leukemia
|
Gao, Mengge
|
|
|
99 |
11 |
p. 2703-2704
|
artikel
|
| 27 |
Risk factors associated with increased emergency department utilization in patients with sickle cell disease: a systematic literature review
|
Ballas, Samir K.
|
|
|
99 |
11 |
p. 2483-2495
|
artikel
|
| 28 |
Tocilizumab for the treatment of TAFRO syndrome: a systematic literature review
|
Akiyama, Mitsuhiro
|
|
|
99 |
11 |
p. 2463-2475
|
artikel
|
| 29 |
Treatment outcomes and chronicity predictors for primary immune thrombocytopenia: 10-year data from an academic center
|
Jaime-Pérez, José Carlos
|
|
|
99 |
11 |
p. 2513-2520
|
artikel
|
| 30 |
Use of carbapenems and glycopeptides increases risk for Clostridioides difficile infections in acute myeloid leukemia patients undergoing intensive induction chemotherapy
|
Ballo, Olivier
|
|
|
99 |
11 |
p. 2547-2553
|
artikel
|
| 31 |
Very long-term follow-up of aplastic anemia treated with immunosuppressive therapy or allogeneic hematopoietic cell transplantation
|
Drexler, Beatrice
|
|
|
99 |
11 |
p. 2529-2538
|
artikel
|
| 32 |
Very-low-dose decitabine treatment for patients with intermediate- or high-risk myelodysplastic syndrome: a retrospective analysis of thirteen cases
|
Zhang, Kaiji
|
|
|
99 |
11 |
p. 2539-2546
|
artikel
|
Tijdschrift beschrijving